Langoyan, Dario S.
HRN: 21-95-26 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/11/2022
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
10/11/2022
10/18/2022
IV
4.5
Q6h
Gas Gangrene
Waiting Final Action
Indication: Empiric Type of Infection: Bone & JointSkin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes